Dealbreaker on MSN
Startup Fortitude Bio launches to beat drug resistance in cancer, expand ADCs to autoimmune disease
The company joins a group of degrader ADC (or DAC) developers that includes Bristol Myers Squibb and Pfizer.
Tropical disease drug discovery is an interdisciplinary field at the intersection of medicinal chemistry, computational biology, and global health. Despite ...
Risk assessments of drug-related problems for cardiac surgery patients can be conducted by implementing a framework for patient safety. Objectives: Patients undergoing cardiac surgery are considered ...
The Healthy @Reader's Digest on MSN
More than 30,000 prescribed cholesterol drugs recalled nationwide
Details suggest two separate medications may present health risks.
Types of errors were analyzed on three levels: (1) the stage of the drug-use process in which the error occurred, (2) the reported type of drug therapy problem, and ...
ND0612 is an investigational drug-device therapy that provides a 24-hour continuous subcutaneous infusion of levodopa/carbidopa solution. The Food and Drug Administration (FDA) has accepted for review ...
US biotech firm Fractyl Health is developing Rejuva, an experimental gene therapy that may mimic GLP-1 drugs for years after ...
Led by Hannes Stärk, a PhD student at MIT and first author, the latest update to the Boltz series of models, BoltzGen, expands the druggable universe by advancing from structure prediction to ...
Researchers at Mass General Brigham are studying a drug that in clinical trials helped early morning shift workers stay more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results